Simplex Trading’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Simplex Trading’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,115,600	Closed	-$189K	–	11161
2022 Q3	$189K	Buy	1,115,600 +148,500	+15%	+$137K	﹤0.01%	4690
2022 Q2	$1.09M	Buy	967,100 +919,047	+1,913%	+$1.52M	﹤0.01%	2516
2022 Q1	$245K	Buy	48,053 +813	+2%	+$5.11K	﹤0.01%	4854
2021 Q4	$266K	Buy	47,240 +20,460	+76%	+$174K	﹤0.01%	4755
2021 Q3	$441K	Buy	26,780 +213	+0.8%	+$2.68K	﹤0.01%	4284
2021 Q2	$450K	Buy	26,567 +26,513	+49,098%	+$503K	﹤0.01%	4329
2021 Q1	$140K	Buy	+54	New	+$2.45K	﹤0.01%	5281

Simplex Trading's EVFM Position: Q4 2022 in Review

Simplex Trading sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2022, closing a stake of 546 shares.

Simplex Trading first reported a position in EVFM in Q2 2020 and held it in 10 quarters. The position peaked at $41K in Q2 2022. 0 funds tracked by Wall St. Rank hold EVFM as of Q4 2022.

Simplex Trading reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 546 Evofem Biosciences, Inc. Common Stock shares in Q4 2022.
Simplex Trading first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Simplex Trading's Evofem Biosciences, Inc. Common Stock position peaked at $41K in Q2 2022.
0 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.